On National Stock Exchange (NSE), the Bank of Maharashtra is quoting Rs 31.75, up 1.44%. The bank’s stock rose 51.91% in 2022, compared with the Nifty’s gain of 1.86% and the Nifty Pharma index’s gain of 52.81%.
- India’s First Hydrogen Train Delayed, Now Expected by June
- UP CM Yogi Adityanath: Unemployment Down, Per Capita GDP Up Since 2017
- India’s Tech Startups Secure $2.5 Billion in Q1 2025, Up 8.7% YoY
- US Trade Envoy to Visit India Before Trump’s Tariff Plan
- Swiggy Instamart Introduces 10-Minute Smartphone Delivery in 10 Cities
On January 13, the bank gained for a third straight session. The stock is quoting at Rs 31.75, up 1.44%. The benchmark Nifty is up around 0.33% daily, with 17,916.25. The Sensex is at 60,168.85, up 0.35%. Bank of Maharashtra has dropped around 6.89% in the previous month.
Meanwhile, the Nifty Pharma index of which Bank of Maharashtra dropped around 6.53% on December 2022 and recently traded the stock at 4,223.1, up 0.71% on the day. As of January 13, 2022, 250.78 lakh shares had traded in the stock, compared with the 732.4 lakh daily average for the previous month.
Based on TTM earnings, the PE of the stock is 12.6 as of September 2022 end.
